BTX - Eterna Therapeutics ...

photo-url-https://images.financialmodelingprep.com/symbol/BTX.png

Eterna Therapeutics Inc.

BTX

NASDAQ

Inactive Equity

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

0.205 USD

0.0001 (0.04876%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Oct 17, 2022 12:00 AM

Share Price on Valuation Date

$0.21

Stock Beta

0.78748

Shares Outstanding

5127070

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.